(Q48006728)

7 February 2018

title

Antibody and clinical responses in volunteers to immunization with malaria peptide-diptheria toxoid conjugates. (English)

1 reference

7 February 2018

0 references

0 references

Ramasamy R

1

1 reference

7 February 2018

Wijesundere DA

series ordinal

2

1 reference

7 February 2018

Nagendran K

series ordinal

3

1 reference

7 February 2018

Ramasamy MS

series ordinal

4

1 reference

7 February 2018

publication date

1 February 1995

1 reference

7 February 2018

Clinical and Experimental Immunology

published in

1 reference

7 February 2018

volume

99

1 reference

7 February 2018

page(s)

168-174

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB05528.X

A method for preparing beta-hCG COOH peptide-carrier conjugates of predictable composition

21 January 2018

1 reference

12 December 2020

Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.

1 reference

12 December 2020

In vitro and in vivo studies on protective and inhibitory antibodies against Plasmodium falciparum in the Saimiri monkey

1 reference

12 December 2020

The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor.

1 reference

12 December 2020

Polymorphism of the precursor for the major surface antigens of Plasmodium falciparum merozoites: studies at the genetic level

1 reference

12 December 2020

Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex.

1 reference

12 December 2020

Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria

1 reference

12 December 2020

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

1 reference

12 December 2020

Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum.

1 reference

12 December 2020

Studies on glycoproteins in the human malaria parasite Plasmodium falciparum. Identification of a myristilated 45kDa merozoite membrane glycoprotein

1 reference

12 December 2020

A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.

1 reference

12 December 2020

Phase I clinical trial of a World Health Organisation birth control vaccine.

1 reference

12 December 2020

Identification of two integral membrane proteins of Plasmodium falciparum

1 reference

12 December 2020

Isolation and partial characterisation of a 26 kilodalton antigen from Plasmodium falciparum recognised by an inhibitory monoclonal antibody

1 reference

12 December 2020

A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules.

1 reference

12 December 2020

Binding of normal human immunoglobulins to Plasmodium falciparum

1 reference

12 December 2020

Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes

1 reference

12 December 2020

Computer prediction of B-cell determinants from protein amino acid sequences based on incidence of beta turns

1 reference

12 December 2020

Characterisation of an inhibitory monoclonal antibody-defined epitope on a malaria vaccine candidate antigen.

1 reference

12 December 2020

A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.

1 reference

12 December 2020

Use of Prior Vaccinations for the Development of New Vaccines

1 reference

12 December 2020

Phase I Clinical Trial of a Recombinant Malaria Vaccine Consisting of the Circumsporozoite Repeat Region of Plasmodium Falciparum Coupled to Hepatitis B Surface Antigen

1 reference

12 December 2020

Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax

1 reference

12 December 2020

The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity

1 reference

12 December 2020

Immunogenicity and Efficacy Trials in Aotus Nancymai Monkeys with Model Compounds Representing Parts of a 75-kD Merozoite Surface Antigen of Plasmodium Falciparum

1 reference

12 December 2020

A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth

1 reference

12 December 2020

Synthetic peptides in malaria research

1 reference

12 December 2020

Circulating cellular immune response to oral immunization of humans with cholera toxin B-subunit

1 reference

12 December 2020

Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia.

1 reference

12 December 2020

Immunogenicity of the Plasmodium falciparum asexual blood-stage synthetic peptide vaccine SPf66.

1 reference

12 December 2020

Influence of N-terminal amino acids & conjugation position to carrier on specificities of antibodies elicited by malaria peptides.

1 reference

12 December 2020

Prediction of protein antigenic determinants from amino acid sequences

1 reference

12 December 2020

10.1111/J.1365-2249.1995.TB05528.X

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

7851007

1 reference

7 February 2018